Huang Foundation's GPU Deal With CoreWeave Hands CRWV a Post-Earnings Bounce

The Catalyst Buried in a Proxy Filing

Nvidia's annual proxy dropped a line that wasn't in any earnings call: the Huang Foundation, the charitable vehicle tied to Jensen and Lori Huang, entered an agreement to buy GPU compute time from CoreWeave. The compute is then donated to universities and nonprofit research institutes for open research, and per the filing the foundation has distributed $108 million in GPU compute grants to date.

The mechanics matter more than the dollar size. This isn't a financial backstop or another strategic equity round — those have already happened, including Nvidia's $2 billion January investment at $87.20 per share. It's an ecosystem-support optic that lands on the tape just as CRWV was being repriced for near-term margin compression. The disclosure also reinforces the read that Nvidia's orbit treats CoreWeave as the preferred venue to actually run GPUs at scale, not just a logo on a press release.

A Bounce, Not a Recovery

The 8.86% move sounds large until you check the chart. CRWV ran to roughly $138 on May 6 on the back of a wave of analyst target hikes, then closed at $107.75 on May 12 after a brutal week unwound the entire run.

The proximate cause was the Q1 print. Revenue beat at $2.08 billion versus a $1.97 billion LSEG consensus, more than doubling year-over-year, but Q2 guidance came in at a $2.45-2.6 billion range — the $2.53 billion midpoint roughly $160 million short of the $2.69 billion consensus. 2026 capex got walked up to $31-35 billion from $30-35 billion on higher component prices, and the CFO explicitly flagged that adjusted operating income was lower than expected because infrastructure was being deployed ahead of schedule. The bounce to $111 reclaims only a fraction of that damage.

Where the Targets Sit

Sell-side price targets had been moving the other direction in the days before the print. Bank of America took CRWV to $140 from $120 on May 6, citing relentless AI inference demand. Deutsche Bank went to $135, and Roth Capital pushed as high as $150, all at Buy. Even after the post-earnings flush, those targets still sit comfortably above the $111 spot, which is why a fresh narrative beat — even a soft one like a charitable foundation disclosure — was enough to move price.

The structural thesis is the one that took the stock up nearly 60% YTD: a $99.4 billion revenue backlog, ten clients committed to $1 billion or more each, and Meta's incremental $21 billion 2027-2032 commitment anchoring the order book. The bear case hasn't broken either — leverage is high, margin compression is real, and Q2 guidance just confirmed that capex is outrunning cash. Today is the bull side getting one good day to catch its breath.